Raptech Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 09-07-2024
- Paid Up Capital ₹ 8.20 M
as on 09-07-2024
- Company Age 6 Year, 12 Days
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2020)
- Profit -93.61%
(FY 2020)
- Ebitda -32.24%
(FY 2020)
- Net Worth -66.83%
(FY 2020)
- Total Assets 21.26%
(FY 2020)
About Raptech Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 8.20 M, as per Ministry of Corporate Affairs (MCA) records.
Rajivkumar Singh, Amrendar Singh, Dipen Jethwa, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999MH2018PTC318166
- Company No.
318166
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Dec 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Raigarh, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Raptech Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajivkumar Singh  | Managing Director | 12-Dec-2018 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Amrendar Singh | Director | 12-Dec-2018 | Current |
Dipen Jethwa  | Director | 16-Feb-2019 | Current |
| Rakeshbhai Patel | Director | 16-Feb-2019 | Current |
Financial Performance of Raptech Laboratories.
Raptech Laboratories Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 93.61% decrease in profit. The company's net worth observed a substantial decline by a decrease of 66.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Raptech Laboratories?
In 2020, Raptech Laboratories had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Raptech Pharma Technologies Private LimitedActive 6 years 8 monthsRajivkumar Singh and Amrendar Singh are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Raptech Laboratories?
Unlock and access historical data on people associated with Raptech Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Raptech Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raptech Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
